Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05207163
Other study ID # 511/TÐHYKPNT-HÐÐÐ
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date February 10, 2022
Est. completion date April 2023

Study information

Verified date September 2022
Source Pham Ngoc Thach University of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of study is identifying the effectiveness of 'continuing medical education' (CME) to primary healthcare worker to improve knowledge about viral hepatitis B-C


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 88
Est. completion date April 2023
Est. primary completion date February 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 24 Years to 65 Years
Eligibility Inclusion Criteria: - Currently working at Outpatient department, Primary-level hospitals - Having Practicing Certificate - Not attending any long-term education - Accepting ICF Exclusion Criteria: - Not attending the full number of lessons - Not answering the questionnaire

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Continuing medical education
Education section about knowledge of transmissions, severity of viral hepatitis B-C and update treatment strategy of the HBV-HCV

Locations

Country Name City State
Vietnam Lê H?ng Ð?c Tháng 07 Ho Chi Minh City

Sponsors (1)

Lead Sponsor Collaborator
Pham Ngoc Thach University of Medicine

Country where clinical trial is conducted

Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Test Scores on Knowledge about Hepatitis B-C from Baseline to 6 months Participants have exams pre- and post-6-months-course, which is multiple choice questions. The test score is average number of correct answers. The pre- and post-6-months exams use the same structure and questions. A change in test score is the difference between test score of the post-6-months-exam and test score of the pre-course-exam. 6 months
See also
  Status Clinical Trial Phase
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT01195181 - Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice. Phase 4
Completed NCT04371276 - Seroepidemiology of Viral Hepatitis in Hong Kong
Completed NCT01988753 - Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
Not yet recruiting NCT04113915 - Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
Recruiting NCT03743272 - Repeatability and Reproducibility of Multiparametric MRI
Completed NCT06360484 - Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus
Recruiting NCT01766895 - Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan
Not yet recruiting NCT04222803 - VIRal Hepatitis and GAllstone Disease Study
Recruiting NCT04304612 - A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases
Completed NCT04062253 - Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid
Recruiting NCT03933384 - Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B Phase 4
Completed NCT01082419 - Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity N/A